Should Angiotensin Receptor Neprilysin Inhibitors Replace Angiotensin-converting Enzyme Inhibitors in Heart Failure With a Reduced Ejection Fraction?

Angiotensin-converting enzyme inhibitors (ACEIs) have been the cornerstone of treatment of heart failure with reduced ejection fraction (HFrEF) for over two decades. Inhibition of neprilyisin augments vasoactive substances including natriuretic peptides, which may have multiple advantageous effects...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Card Fail Rev
Päätekijät: Hayman, Sam, Atherton, John J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Radcliffe Cardiology 2016
Aiheet:
Pharmacological Therapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5490929/
https://ncbi.nlm.nih.gov/pubmed/28785452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/cfr.2016:2:2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia